ConductScience.org, home

Paper41398607

Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.

Wang J and 15 others. J Nanobiotechnology, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles. Papers, record 41398607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398607

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-27
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JJingru
2Yao BBo
3Zhang YYutian
4Liu SShuya
5Liu WWeiming
6Han YYutong
7Shi KKaiyuan
8Han WWenyi
9Li RRuonan
10Cai ZZhihui
11Yang HHui
12Ling QQinjie
13He JJingjun
14Liu FFei
15Gou SShan
16Huang ZZhi

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
NanoparticlesMajor topic
Muscle, Smooth, VascularMajor topic
MacrophagesMajor topic
SeleniumMajor topic
OligodeoxyribonucleotidesMajor topic
Myocytes, Smooth MuscleMajor topic
Immunosuppressive AgentsMajor topic
Animals
Mice
Phenotype
Male
Mice, Inbred C57BL
Oxidative Stress
Mice, Knockout, ApoE

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2024BSGZ21Science Foundations of Guangdong Second Provincial General HospitalPubMed
TJGC-2025002Science Foundations of Guangdong Second Provincial General HospitalPubMed
82300506National Natural Science Foundation of ChinaPubMed
82300958National Natural Science Foundation of ChinaPubMed
82270471National Natural Science Foundation of ChinaPubMed
2023M731315China Postdoctoral Science FoundationsPubMed
2023M731316China Postdoctoral Science FoundationsPubMed
2022A1515010253Natural Science Foundation of Guangdong ProvincePubMed
202206010033Major Project of Science and Technology of GuangzhouPubMed

Source PubMed

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136935493Theranostic applications of selenium nanomedicines against lung cancer.J Nanobiotechnology2023https://conductscience.org/library/papers/36935493PubMed
225686105A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.Nat Med2015https://conductscience.org/library/papers/25686105PubMed
328643462Selenium-Doped Carbon Quantum Dots for Free-Radical Scavenging.Angew Chem Int Ed Engl2017https://conductscience.org/library/papers/28643462PubMed
439061065Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.J Nanobiotechnology2024https://conductscience.org/library/papers/39061065PubMed
534273166Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells.Cardiovasc Res2022https://conductscience.org/library/papers/34273166PubMed
635008765NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.Int J Mol Sci2021https://conductscience.org/library/papers/35008765PubMed
731200144Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy.Biomaterials2019https://conductscience.org/library/papers/31200144PubMed
829875409Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.Nature2018https://conductscience.org/library/papers/29875409PubMed
934505766Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.ACS Nano2021https://conductscience.org/library/papers/34505766PubMed
1035041278Engineering CXCL12 Biomimetic Decoy-Integrated Versatile Immunosuppressive Nanoparticle for Ischemic Stroke Therapy with Management of Overactivated Brain Immune Microenvironment.Small Methods2022https://conductscience.org/library/papers/35041278PubMed
1134639053The Impact of Selenium Deficiency on Cardiovascular Function.Int J Mol Sci2021https://conductscience.org/library/papers/34639053PubMed
1222381456Selenium and human health.Lancet2012https://conductscience.org/library/papers/22381456PubMed
1338145971Hypertensive Pressure Mechanosensing Alone Triggers Lipid Droplet Accumulation and Transdifferentiation of Vascular Smooth Muscle Cells to Foam Cells.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38145971PubMed
1440690813Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.Redox Biol2025https://conductscience.org/library/papers/40690813PubMed
1528062653Anticoagulation, atherosclerosis, and heart failure.Eur Heart J Cardiovasc Pharmacother2017https://conductscience.org/library/papers/28062653PubMed
1629315675Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.Med Res Rev2018https://conductscience.org/library/papers/29315675PubMed
1739400451Intracellular Redox Environment Determines Cancer-normal Cell Selectivity of Selenium Nanoclusters.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/39400451PubMed
1839568027Neutrophil extracellular traps facilitate liver inflammation/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis.Cell Commun Signal2024https://conductscience.org/library/papers/39568027PubMed
1928981106NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension.Cell Death Dis2017https://conductscience.org/library/papers/28981106PubMed
2034121366Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics.Adv Healthc Mater2021https://conductscience.org/library/papers/34121366PubMed

See all 56 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42985392Selenium Nanoparticles in Atherosclerosis and Non-Alcoholic Fatty Liver Disease: A Comprehensive Review of Therapeutic Mechanisms, Targeted Delivery, and Translational Prospects.Int J Nanomedicine2026https://conductscience.org/library/papers/42985392

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41398607

GET https://conductscience.org/api/papers/v1/41398607/references?page=2